Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

NCT00013871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +38 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 40 locations
View Trial Details
Completed

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants

NCT02927873

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Topeka, Kansas, United States
  • GSK Investigational Site Frederick, Maryland, United States
View all 24 locations
View Trial Details
Completed

A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

NCT03674177

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Rochester, New York, United States
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Tampere, Finland
View Trial Details
Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT01968083

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hospital at Long Beach Memorial Medical Center Long Beach, California, United States
  • The Children's Hospital University of Colorado Denver, Colorado, United States
  • Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States
View Trial Details

Related conditions